These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

87 related articles for article (PubMed ID: 10395282)

  • 1. Absolute and atropisomeric structure of ES-242s, N-methyl-D-aspartate receptor antagonists.
    Tatsuta K; Nagai T; Mase T; Tamura T; Nakamura H
    J Antibiot (Tokyo); 1999 Apr; 52(4):433-6. PubMed ID: 10395282
    [No Abstract]   [Full Text] [Related]  

  • 2. Synthesis of an N-methyl-D-aspartate receptor antagonist, ES-242-5, and its analogs.
    Tatsuta K; Nagai T; Mase T; Yamazaki T; Tamura T
    J Antibiot (Tokyo); 1999 Apr; 52(4):422-5. PubMed ID: 10395279
    [No Abstract]   [Full Text] [Related]  

  • 3. The neuroprotective properties of ES-242s, novel NMDA receptor antagonists, in neuronal cell culture toxicity studies.
    Nozawa M; Toki S; Matsuda Y
    Eur J Pharmacol; 1993 May; 236(2):263-8. PubMed ID: 8100531
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Synthesis and biological evaluation of the analogs of bioxanthracenes ES-242s, N-methyl-D-aspartate antagonists.
    Tatsuta K; Yamazaki T; Yoshimoto T
    J Antibiot (Tokyo); 1998 Mar; 51(3):383-6. PubMed ID: 9589079
    [No Abstract]   [Full Text] [Related]  

  • 5. Studies on cerebral protective agents. IX. Synthesis of novel 1,2,3,4-tetrahydroisoquinolines as N-methyl-D-aspartate antagonists.
    Ohkubo M; Kuno A; Katsuta K; Ueda Y; Shirakawa K; Nakanishi H; Nakanishi I; Kinoshita T; Takasugi H
    Chem Pharm Bull (Tokyo); 1996 Jan; 44(1):95-102. PubMed ID: 8582046
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Synthesis and pharmacological evaluation of N-(2,5-disubstituted phenyl)-N'-(3-substituted phenyl)-N'-methylguanidines as N-methyl-D-aspartate receptor ion-channel blockers.
    Hu LY; Guo J; Magar SS; Fischer JB; Burke-Howie KJ; Durant GJ
    J Med Chem; 1997 Dec; 40(26):4281-9. PubMed ID: 9435897
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Conformational analysis of the NMDA receptor antagonist (1S,2R)-1-phenyl-2-[(S)-1-aminopropyl]-N,N-diethylcyclopropanecarboxamide (PPDC) designed by a novel conformational restriction method based on the structural feature of cyclopropane ring.
    Ono S; Ogawa K; Yamashita K; Yamamoto T; Kazuta Y; Matsuda A; Shuto S
    Chem Pharm Bull (Tokyo); 2002 Jul; 50(7):966-8. PubMed ID: 12130856
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Two intermediates in the synthesis of decahydroisoquinolines with NMDA and AMPA receptor antagonist activity.
    Zukerman-Schpector J; Vega M; Caracelli I; Dias LC; Fernandes AM
    Acta Crystallogr C; 2001 Sep; 57(Pt 9):1089-91. PubMed ID: 11588380
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The N-methyl-D-aspartate receptor channel blockers memantine, MRZ 2/579 and other amino-alkyl-cyclohexanes antagonise 5-HT(3) receptor currents in cultured HEK-293 and N1E-115 cell systems in a non-competitive manner.
    Rammes G; Rupprecht R; Ferrari U; Zieglgänsberger W; Parsons CG
    Neurosci Lett; 2001 Jun; 306(1-2):81-4. PubMed ID: 11403963
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The competitive NMDA receptor antagonist SDZ 220-581 reverses haloperidol-induced catalepsy in rats.
    McAllister KH
    Eur J Pharmacol; 1996 Oct; 314(3):307-11. PubMed ID: 8957251
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Synthesis of 1,4,7,8,9,10-hexahydro-9-methyl-6-nitropyrido[3,4-f]- quinoxaline-2,3-dione and related quinoxalinediones: characterization of alpha-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid (and N-methyl-D-aspartate) receptor and anticonvulsant activity.
    Bigge CF; Malone TC; Boxer PA; Nelson CB; Ortwine DF; Schelkun RM; Retz DM; Lescosky LJ; Borosky SA; Vartanian MG
    J Med Chem; 1995 Sep; 38(19):3720-40. PubMed ID: 7562904
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Synthesis and pharmacological evaluation of conformationally constrained glutamic acid higher homologues.
    Tamborini L; Cullia G; Nielsen B; De Micheli C; Conti P; Pinto A
    Bioorg Med Chem; 2016 Nov; 24(22):5741-5747. PubMed ID: 27658797
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Neuroprotective effects of functional antagonists at the glycine site of the NMDA receptor.
    Trullas R
    Methods Find Exp Clin Pharmacol; 1997; 19 Suppl A():55-6. PubMed ID: 9403859
    [No Abstract]   [Full Text] [Related]  

  • 14. Protective use of N-methyl-D-aspartate receptor antagonists as a spinoplegia against excitatory amino acid neurotoxicity.
    Cho Y; Ueda T; Mori A; Shimizu H; Haga Y; Yozu R
    J Vasc Surg; 2005 Oct; 42(4):765-71. PubMed ID: 16242566
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Subtype-selective N-methyl-D-aspartate receptor antagonists: benzimidazalone and hydantoin as phenol replacements.
    Schelkun RM; Yuen PW; Serpa K; Meltzer LT; Wise LD; Whittemore ER; Woodward RM
    J Med Chem; 2000 May; 43(9):1892-7. PubMed ID: 10794706
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Excitatory amino acid receptor antagonists: resolution, absolute stereochemistry, and pharmacology of (S)- and (R)-2-amino-2-(5-tert-butyl-3-hydroxyisoxazol-4-yl)acetic acid (ATAA).
    Johansen TN; Frydenvang K; Ebert B; Madsen U; Krogsgaard-Larsen P
    Chirality; 1997; 9(5-6):529-36. PubMed ID: 9329180
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Neuroprotective concentrations of the N-methyl-D-aspartate open-channel blocker memantine are effective without cytoplasmic vacuolation following post-ischemic administration and do not block maze learning or long-term potentiation.
    Chen HS; Wang YF; Rayudu PV; Edgecomb P; Neill JC; Segal MM; Lipton SA; Jensen FE
    Neuroscience; 1998 Oct; 86(4):1121-32. PubMed ID: 9697119
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Model structures of the N-methyl-D-aspartate receptor subunit NR1 explain the molecular recognition of agonist and antagonist ligands.
    Moretti L; Pentikäinen OT; Settimo L; Johnson MS
    J Struct Biol; 2004 Mar; 145(3):205-15. PubMed ID: 14960371
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Enantiomeric propanolamines as selective N-methyl-D-aspartate 2B receptor antagonists.
    Tahirovic YA; Geballe M; Gruszecka-Kowalik E; Myers SJ; Lyuboslavsky P; Le P; French A; Irier H; Choi WB; Easterling K; Yuan H; Wilson LJ; Kotloski R; McNamara JO; Dingledine R; Liotta DC; Traynelis SF; Snyder JP
    J Med Chem; 2008 Sep; 51(18):5506-21. PubMed ID: 18800760
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Synthesis of a series of γ-amino alcohols comprising an N-methyl isoindoline moiety and their evaluation as NMDA receptor antagonists.
    Müller A; Höfner G; Renukappa-Gutke T; Parsons CG; Wanner KT
    Bioorg Med Chem Lett; 2011 Oct; 21(19):5795-9. PubMed ID: 21875803
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.